Karyopharm Therapeutics Inc (KPTI): A Technical Analysis
KPTI has 36-month beta value of 0.22. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy”, 2 as “overweight”, 1 as “hold”, and 0 as “sell”. The public float for KPTI is 16.91M, and currently, short sellers hold a 7.99% ratio of that float. The average trading volume of … Read more